Nasal Allergen Neutralising IgG4 Antibodies Block IgE-mediated Responses: Novel biomarker of Subcutaneous Grass Pollen Immunotherapy

Immunotherapy

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.

JAMA.

Scadding GW, Calderon MA, Shamji MH, Eifan AO, Penagos M, Dumitru F, Sever ML, Bahnson HT, Lawson K, Harris KM, Plough AG, Panza JL, Qin T, Lim N, Tchao NK, Togias A, Durham SR

doi: 10.1001/jama.2016.21040.

Allergic DiseasesImmunotherapy

Basophil Sensitivity Reflects the Long-term Clinical Outcome of Subcutaneous Immunotherapy in Grass Pollen Allergic Patients

Allergy.

Schmid JM, Würtzen PA, Siddhuraj P, Jogdand P, Petersen CG, Dahl R, Erjefält JS, Hoffmann HJ

doi: 10.1111/all.14264.

Allergic Diseases

Sensitization to grass pollen allergen molecules in a birth cohort - Phl p 4 as early indicator of grass pollen allergy

J Allergy Clin Immunol.

Westman M, Åberg K, Apostolovic D, Lupinek C, Gattinger P, Mittermann I, Andersson N, Melén E, Bergström A, Antó JM, Bousquet J, Valenta R, Wickman M, van Hage M, MeDALL consortium.

doi: 10.1016/j.jaci.2020.01.006.

Allergic Diseases

Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy

J Allergy Clin Immunol.

Rodríguez-Domínguez A, Berings M, Rohrbach A, Huang HJ, Curin M, Gevaert P, Matricardi PM, Valenta R, Vrtala S

doi: 10.1016/j.jaci.2020.03.029.

Immunotherapy

Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen season

J Allergy Clin Immunol.

Ellis AK, Frankish CW, Armstrong K, Steacy L, Tenn MW, Pawsey S, Hafner RP

doi: 10.1016/j.jaci.2019.09.010.

Allergic DiseasesImmunotherapy

Systemic and large local reactions during subcutaneous grass pollen immunotherapy in children

Pediatr Allergy Immunol.

Gur Cetinkaya P, Kahveci M, Esenboga S, Karaatmaca B, Soyer O, Sekerel BE, Tuncer A, Sahiner UM

doi: 10.1111/pai.13261.

Allergic DiseasesImmunotherapy

Intralymphatic Immunotherapy improves grass pollen allergic rhinoconjunctivitis. A three-year randomized placebo-controlled trial

J Allergy Clin Immunol.

Skaarup SH, Schmid JM, Skjold T, Graumann O, Hoffmann HJ

doi: 10.1016/j.jaci.2020.07.002.

Allergic Diseases

Ovomucoid epitope-specific repertoire of IgE, IgG₄ , IgG₁ , IgA₁ and IgD antibodies in egg allergic children

Allergy.

Suprun M, Getts R, Grishina G, Tsuang A, Suárez-Fariñas M, Sampson HA

doi: 10.1111/all.14357.

Immunotherapy

Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis

Allergy.

Nurmatov U, Dhami S, Arasi S, Pajno GB, Fernandez-Rivas M, Muraro A, Roberts G, Akdis C, Alvaro-Lozano M, Beyer K, Bindslev-JensenC, Burks W, du Toit G, Ebisawa M, Eigenmann P, Knol E, Makela M, Nadeau KC, O'Mahony L, Papadopoulos N, Poulsen LK, Sackesen C, Sampson H, Santos AF, van Ree R, Timmermans F, Sheikh A

doi: 10.1111/all.13124.

Dermatology · Immunology · Rheumatology

Nasal Allergen Neutralising IgG₄ Antibodies Block IgE-mediated Responses: Novel biomarker of Subcutaneous Grass Pollen Immunotherapy

Related content

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.

Basophil Sensitivity Reflects the Long-term Clinical Outcome of Subcutaneous Immunotherapy in Grass Pollen Allergic Patients

Sensitization to grass pollen allergen molecules in a birth cohort - Phl p 4 as early indicator of grass pollen allergy

Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy

Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen season

Systemic and large local reactions during subcutaneous grass pollen immunotherapy in children

Intralymphatic Immunotherapy improves grass pollen allergic rhinoconjunctivitis. A three-year randomized placebo-controlled trial

Ovomucoid epitope-specific repertoire of IgE, IgG4 , IgG1 , IgA1 and IgD antibodies in egg allergic children

Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis

Ovomucoid epitope-specific repertoire of IgE, IgG₄ , IgG₁ , IgA₁ and IgD antibodies in egg allergic children